Investor desk
Investors should track partnership announcements and pipeline signals from CPhI.
← Back to Events
Tier 1 Global Networking: High MANUFACTURING CONCLUDED
CPhI — 2026 — Tokyo International Exhibition Center (Tokyo Big Sight), Tokyo, Japan
International Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector.
5,000+ Attendees
Presentation data updated May 4, 2026, 9:07 PM UTC
Why This Event Matters
International Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector.
Industry impact
International Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector..
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in APAC markets.
Regulatory implications
EMA and national HTA frameworks are frequently debated at industry gatherings.
Investor implications
Investors should track partnership announcements and pipeline signals from CPhI.
Competitive implications
Competitive positioning among manufacturing players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
36 /100 composite
CPhI is a targeted manufacturing forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 20/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
manufacturingNot specifiedPipeline announcements
Key Markets
Asia-Pacific
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Complete
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Apr 21, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
Nova editorial monitors confirmed data releases.
- Conference closes Apr 23, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefInternational Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
EMA and national HTA frameworks are frequently debated at industry gatherings.
Competitive intelligence
Competitive positioning among manufacturing players is a core theme — compare with prior editions.
Competitive Landscape
Company map →Competitive positioning among manufacturing players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for CPhI — optimized for research and AI retrieval.
Executive Summary
International Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector.
Analyst View
International Exhibition on Pharmaceutical Ingredients and Intermediates, convening the global pharma community for networking, alliances, and advancing the Japanese pharma sector..
Investor View
Investors should track partnership announcements and pipeline signals from CPhI.
BD View
BD teams should prioritize partnership and licensing conversations at CPhI.
Key Facts
- Event
- CPhI
- Focus
- manufacturing
- Region
- Asia-Pacific
- Attendance
- 5,000+
- Location
- Tokyo, Japan
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is CPhI?
CPhI is a manufacturing industry conference for executives, clinical leaders, and investors.
Who attends CPhI?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on manufacturing.
Why is CPhI important?
CPhI influences partnership timing and policy debates affecting manufacturing markets for the next 12–18 months.
Where is CPhI held?
CPhI is held in Tokyo, Japan.
What should investors watch at CPhI?
Track partnership announcements, pipeline readouts, and management commentary on manufacturing catalysts.
What BD opportunities exist at CPhI?
BD teams use CPhI for licensing, co-development, and vendor selection across manufacturing.
How does CPhI compare with other pharma conferences?
CPhI is a tier-1 global congress for manufacturing — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of CPhI?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.